Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(71.4%)
Phase 2
2(28.6%)
7Total
N/A(5)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07568483Not ApplicableRecruiting

TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System

Role: collaborator

NCT05781893Active Not Recruiting

Basel Long COVID-19 Cohort Study and Digital Long COVID Substudy

Role: collaborator

NCT06047262Phase 2Recruiting

Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia

Role: collaborator

NCT03935321Phase 2Completed

NISCI - Nogo Inhibition in Spinal Cord Injury

Role: collaborator

NCT04821037Not ApplicableUnknown

Nurse Health Pilot: Feasibility and Acceptability of a Virtual ACT-intervention in Nurses During COVID-19

Role: collaborator

NCT03108092Not ApplicableCompleted

Health Economic Evaluation Alongside the OPERAM Trial

Role: collaborator

NCT02986425Not ApplicableCompleted

OPtimising thERapy to Prevent Avoidable Hospital Admissions in the Multimorbid Older People

Role: collaborator

NCT02077049Not ApplicableCompleted

Are Serious Games Promoting Mobility an Attractive Alternative to Conventional Self-training for Elderly People?

Role: collaborator

All 8 trials loaded